Baxter
Baxter International outperform – New Analyst Rating from RBC Capital Markets
Monday, April 23rd, 2012Baxter International buy – New Analyst Rating from UBS AG
Monday, April 23rd, 2012Baxter International outperform – New Analyst Rating from RBC Capital Markets
Wednesday, April 18th, 2012Baxter International buy – New Analyst Rating from UBS AG
Friday, March 23rd, 2012Baxter International buy – New Analyst Rating from UBS AG
Wednesday, February 29th, 2012Baxter International buy – New Analyst Rating from UBS AG
Tuesday, February 28th, 2012Baxter International outperform – New Analyst Rating from RBC Capital Markets
Thursday, February 23rd, 2012Baxter International outperform – New Analyst Rating from RBC Capital Markets
Thursday, February 16th, 2012Baxter International outperform – New Analyst Rating from RBC Capital Markets
Wednesday, February 15th, 2012Baxter International outperform – New Analyst Rating from RBC Capital Markets
Monday, January 30th, 2012Baxter International outperform – New Analyst Rating from RBC Capital Markets
Tuesday, January 24th, 2012Baxter ( BAX ) Initial Recommendation Buy – Analyst rating from Standpoint Research
Thursday, January 5th, 2012Baxter (BAX) Initial Recommendation – Buy – Analyst rating from Standpoint Research
Thursday, January 5th, 2012Baxter International outperform – New Analyst Rating from Morgan Keegan & Co., Inc.
Tuesday, August 16th, 2011Baxter ( BAX ) Initial Recommendation Buy – Analyst rating from Brean Murray
Wednesday, June 15th, 2011Baxter (BAX) Initial Recommendation – Buy – Analyst rating from Brean Murray
Wednesday, June 15th, 2011Baxter International equal-weight – New Analyst Rating from Barclays Capital
Wednesday, April 27th, 2011Baxter International equal-weight – New Analyst Rating from Barclays Capital
Friday, March 4th, 2011Baxter International equal-weight – New Analyst Rating from Barclays Capital
Monday, January 31st, 2011Baxter International equal-weight – New Analyst Rating from Barclays Capital
Wednesday, January 26th, 2011Baxter International outperform – New Analyst Rating from Morgan Keegan & Co., Inc.
Thursday, October 7th, 2010Baxter International outperform – New Analyst Rating from Morgan Keegan & Co., Inc.
Wednesday, October 6th, 2010Baxter “average” – New Analyst Rating from Caris & Company, Inc.
Thursday, July 1st, 2010Baxter “average” – New Analyst Rating from Caris & Company, Inc.
Wednesday, June 30th, 2010Baxter “average” – New Analyst Rating from Caris & Company, Inc.
Monday, June 28th, 2010Baxter ( BAX ) Initial Recommendation Average – Analyst rating from Caris & Company
Friday, June 25th, 2010Baxter “average” – New Analyst Rating from Caris & Company, Inc.
Friday, June 25th, 2010Baxter (BAX) Initial Recommendation – Average – Analyst rating from Caris & Company
Friday, June 25th, 2010Baxter (BAX) Downgrade from Buy to Hold – Analyst rating from Argus
Tuesday, May 11th, 2010Baxter ( BAX ) Downgrade from Buy to Hold – Analyst rating from Argus
Tuesday, May 11th, 2010Baxter “buy” – New Analyst Rating from UBS AG
Tuesday, April 27th, 2010Baxter (BAX) Downgrade from Overweight to Neutral – Analyst rating from JP Morgan
Monday, April 26th, 2010Baxter neutral – New Analyst Rating from JP Morgan Chase & Co.
Monday, April 26th, 2010Baxter ( BAX ) Downgrade from Overweight to Neutral($55) – Analyst rating from JP Morgan
Monday, April 26th, 2010Baxter “market perform” – New Analyst Rating from William Blair
Monday, April 26th, 2010Baxter ( BAX ) Downgrade from Outperform to Mkt Perform – Analyst rating from William Blair
Friday, April 23rd, 2010Baxter (BAX) Downgrade from Outperform to Mkt Perform – Analyst rating from William Blair
Friday, April 23rd, 2010Baxter (BAX) Downgrade from Buy to Hold – Analyst rating from Citigroup
Tuesday, January 19th, 2010Baxter (BAX) Upgrade from Mkt Perform to Outperform – Analyst rating from Morgan Keegan
Thursday, January 14th, 2010Fortune – 10 best stocks for 2010 – Baxter International BAX
Monday, December 14th, 2009Baxter makes a wide range of indispensable products, which are likely to prosper regardless of potential changes like cost cutting or increased generic drug use. Moreover, Baxter currently garners 60% of its sales from outside the U.S., and Piper Jaffray analyst Matt Miksic expects significant growth in those regions. The company aims at highly specific [...]